Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11286294 Anti-RSV monoclonal antibody formulation

Patent 11286294 was granted and assigned to Medimmune Limited on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 18, 2021
0
Date of Patent
March 29, 2022
0
Patent Application Number
17351348
0
Patent Citations
‌
US Patent 10016496 Respiratory syncytial virus F protein epitopes
‌
US Patent 10035843 RSV-specific binding molecule
‌
US Patent 10774133 Anti-RSV monoclonal antibody formulation
‌
US Patent 10059757 RSV-specific binding molecules and means for producing them
‌
US Patent 10689437 RSV-specific antibodies and functional parts thereof
0
Patent Citations Received
‌
US Patent 11667698 Anti-RSV monoclonal antibody formulation
0
Patent Inventor Names
Deborah Goldberg
0
Brian Lobo
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11286294
0
Patent Primary Examiner
‌
Stacy B. Chen
0

Find more entities like US Patent 11286294 Anti-RSV monoclonal antibody formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.